ADVANCED OR RECURRENT SOLID TUMORS
Clinical trials for ADVANCED OR RECURRENT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR RECURRENT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR RECURRENT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer vaccine aims to fight advanced tumors when other treatments fail
Disease control Recruiting nowThis study tests a cancer vaccine called EVM16, either by itself or combined with an immune-boosting drug (tislelizumab), in people with advanced or recurrent solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the vaccin…
Matched conditions: ADVANCED OR RECURRENT SOLID TUMORS
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill targets rare cancer gene in last-resort patients
Disease control Recruiting nowThis study tests an experimental drug called E7090 in people with advanced or returning solid tumors that have a specific change in the FGFR gene. About 75 participants will receive the drug to see if it can shrink tumors and control the disease. The goal is to offer a new option…
Matched conditions: ADVANCED OR RECURRENT SOLID TUMORS
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC